» Authors » Valerie Devauchelle

Valerie Devauchelle

Explore the profile of Valerie Devauchelle including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 1061
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Maillet F, Nguyen Y, Espitia O, Perard L, Salvarani C, Riviere E, et al.
Rheumatology (Oxford) . 2025 Feb; PMID: 39898825
Objectives: To describe the characteristics and outcome of patients with the association of large vessel vasculitis (LVV, Takayasu arteritis [TA] or giant cell arteritis [GCA]) and inflammatory bowel disease (IBD)....
2.
Boudigou M, Frutoso M, Hemon P, Le Dantec C, Chatzis L, Devauchelle V, et al.
Clin Immunol . 2024 Oct; 268:110378. PMID: 39393568
The conventional classification of mature B cells overlooks the diversity within IgD CD27 naïve B cells. Here, to identify distinct mature naïve B cells, we categorized CD45RB B cells (NA...
3.
Antoine P, Morell-Dubois S, Maillard H, Wojtasik G, Sanges S, Launay D, et al.
Clin Exp Rheumatol . 2023 Jun; 41(12):2379-2388. PMID: 37389544
Objectives: Sjögren's syndrome (SS) is an autoimmune disease with an impact on quality of life (QoL). The aim of patient education (PE) is to improve patients' QoL. The main objective...
4.
Chausset A, Lambert C, Belot A, Merlin E, Cannizzaro E, Kone-Paut I, et al.
Pediatr Rheumatol Online J . 2023 Mar; 21(1):24. PMID: 36918902
Background: Despite guidelines, poor access to appropriate care for juvenile idiopathic arthritis (JIA) patients remains a global issue. Prompt referral to a pediatric rheumatology (PR) center and effective care is...
5.
Toussirot E, Michaud M, Wendling D, Devauchelle V
J Rheumatol . 2021 Sep; 48(12):1888-1889. PMID: 34526393
No abstract available.
6.
Mouasni S, Gonzalez V, Schmitt A, Bennana E, Guillonneau F, Mistou S, et al.
Cell Death Dis . 2019 Feb; 10(3):190. PMID: 30804327
Fas-associated death domain (FADD) is a key adaptor molecule involved in numerous physiological processes including cell death, proliferation, innate immunity and inflammation. Therefore, changes in FADD expression have dramatic cellular...
7.
Gandjbakhch F, Granger B, Freund R, Foltz V, Jousse-Joulin S, Devauchelle V, et al.
RMD Open . 2017 Jan; 3(1):e000343. PMID: 28123779
Introduction: Structural damage progression is a major outcome in rheumatoid arthritis (RA). Its evaluation and follow-up in trials should involve radiographic scoring by 1 or 2 readers (reference assessment), which...
8.
Devauchelle V, Saraux A
Ann Rheum Dis . 2016 Jun; 75(8):e48. PMID: 27268939
No abstract available.
9.
Seror R, Bowman S, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, et al.
RMD Open . 2015 Oct; 1(1):e000022. PMID: 26509054
The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) is a systemic disease activity index that was designed to measure disease activity in patients with primary SS. With the growing...
10.
Le Dantec C, Alonso R, Fali T, Montero E, Devauchelle V, Saraux A, et al.
Immunol Res . 2013 Apr; 56(2-3):341-7. PMID: 23576060
CD6 is a cell surface receptor expressed on the majority of T cells and a subset of B cells. When expressed, CD6 contributes to lymphocyte activation through its extracellular domain...